|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2003-7-17
|
|
pubmed:abstractText |
The aim of this study was to describe the pharmacokinetics of 3 different single doses of fulvestrant-a new estrogen receptor (ER) antagonist that downregulates the ER with no known agonist effects-administered as a prolonged-release IM formulation.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0149-2918
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1440-52
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12867220-Aged,
pubmed-meshheading:12867220-Aged, 80 and over,
pubmed-meshheading:12867220-Antineoplastic Agents, Hormonal,
pubmed-meshheading:12867220-Area Under Curve,
pubmed-meshheading:12867220-Breast Neoplasms,
pubmed-meshheading:12867220-Chemistry, Pharmaceutical,
pubmed-meshheading:12867220-Delayed-Action Preparations,
pubmed-meshheading:12867220-Estradiol,
pubmed-meshheading:12867220-Female,
pubmed-meshheading:12867220-Half-Life,
pubmed-meshheading:12867220-Humans,
pubmed-meshheading:12867220-Injections, Intramuscular,
pubmed-meshheading:12867220-Postmenopause,
pubmed-meshheading:12867220-Tamoxifen
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Pharmacokinetics of a single dose of fulvestrant prolonged-release intramuscular injection in postmenopausal women awaiting surgery for primary breast cancer.
|
|
pubmed:affiliation |
Nottingham City Hospital, Nottingham, United Kingdom. john.robertson@nottingham.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
